An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial.
Am Heart J
; 200: 17-23, 2018 06.
Article
in En
| MEDLINE
| ID: mdl-29898844
Full text:
1
Database:
MEDLINE
Main subject:
Pyrazoles
/
Pyridones
/
Atrial Fibrillation
/
Warfarin
/
Stroke
/
Acute Coronary Syndrome
/
Percutaneous Coronary Intervention
/
Hemorrhage
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Am Heart J
Year:
2018
Type:
Article